首页
订购/客服:400-666-5481

MRTX-849

    
99.40%

2-PIPERAZINEACETONITRILE, 4-[7-(8-CHLORO-1-NAPHTHALENYL)-5,6,7,8-TETRAHYDRO-2-[[(2S)-1-METHYL-2-PYRR

源叶(MedMol)
S88622 一键复制产品信息
2326521-71-3
C32H35ClFN7O2
604.12
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S88622-5mg买3赠1
99.40%

¥256.00

3 - - - -
S88622-10mg买3赠1
99.40%

¥460.00

3 - - - -
S88622-25mg买3赠1
99.40%

¥970.00

3 - - - -
S88622-50mg买3赠1
99.40%

¥1550.00

4 - - - -
S88622-100mg买3赠1
≥98%

¥2300.00

货期:2-3天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: Adagrasib (MRTX849) 是一种有效的,选择性的和共价的KRAS G12C抑制剂,具有良好的药物样特性,可选择性地修饰GDP结合的KRAS G12C中的突变半胱氨酸12并抑制KRAS依赖性信号传导
靶点: K-Ras(G12C);Ras
体外研究: To evaluate the breadth of MRTX849 activity, its effect on cell viability is determined across a panel of 17 KRASG12C-mutant and three non-KRASG12C-mutant cancer cell lines using 2D (3-day, adherent cells) and 3D (12-day, spheroids) cell growth conditions. MRTX849 potently inhibits cell growth in the vast majority of KRASG12C-mutant cell lines with IC50 values ranging between 10 nM and 973 nM in the 2D format and between 0.2 nM and 1042 nM in the 3D format
体内研究: Rapid tumor regression is observed at the earliest posttreatment tumor measurement and animals in the 30 mg/kg and 100 mg/kg cohorts exhibits evidence of a complete response at study Day 15. Dosing is stopped at study Day 16 and all 4 mice in the 100 mg/kg cohort and 2 out of 7 mice in the 30 mg/kg cohort remains tumor-free through study Day 70
细胞实验: Cell lines: MIA PaCa-2, H1373, H358, H2122, SW1573, H2030, KYSE-410 cells (G12C); H1299 (WT); A549 (G12S), HCT116 (G13D) cells Concentrations: -- Incubation Time: 24 h Method: All cell lines were maintained at 37 ℃ in a humidified incubator at 5% CO2 and were periodically checked for mycoplasma. CellTiter-Glo assay to evaluate cell viability performed on seven KRAS G12C-mutant cell lines and three non-KRAS G12C-mutant cell lines cells grown in 2D tissue culture conditions in a 3-day assay or 3D conditions using 96-well, ULA plates in a 12-day assay.
动物实验: Animal Models: MIA PaCa-2 model Dosages: 3 mg/kg, 10 mg/kg, 30 mg/kg and 100 mg/kg Administration: Oral gavage
参考文献: 1. Jill Hallin,et al. The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients. Cancer Discov.2020;10 (1): 54-71.
溶解性: Soluble  in  DMSO、Ethanol
保存条件: -20°C
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 1.655 ml 8.277 ml 16.553 ml
5 mM 0.331 ml 1.655 ml 3.311 ml
10 mM 0.166 ml 0.828 ml 1.655 ml
50 mM 0.033 ml 0.166 ml 0.331 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×